Study: Medical Marijuana Associated With Reduced Opioid Use in Fibromyalgia Patients

Fibromyalgia patients suffering from lower back pain respond favorably to medical cannabis as a treatment, according to a new study published in the journal Clinical and Experimental Rheumatology, and epublished by the National Institute of Health.

For the study, researchers assessed the analgesic efficacy of both opioids and medical cannabis in 31 fibromyalgia (FM) patients with lower back pain. Participants were treated with inhaled cannabis containing less than 5% THC for a six month period

According to a press release from NORML, patients reported greater pain improvement with medical cannabis as opposed to the use of opioids alone. Patients demonstrated increased range of motion following cannabis treatment, but did not show any similar improvement with opioids. While undergoing cannabis treatment, the majority of patients elected to “decrease or discontinue pharmaceutical analgesic consumption”.

Read moreStudy: Medical Marijuana Associated With Reduced Opioid Use in Fibromyalgia Patients

Study: Marijuana Effective at Treating Fibromyalgia

According to a new study published by the Journal of Clinical Rheumatology,  marijuana had “a significant favorable effect” on fibromyalgia among all participants.

A fibromyalgia word cloud.

“Fibromyalgia is a chronic pain syndrome, characterized by chronic musculoskeletal pain, fatigue, and mood disturbances”, explains the study’s abstract. “There are nearly no data on the effect of medical cannabis (MC) treatment on patients with fibromyalgia.”

For the study, data was obtained “from the registries of 2 hospitals in Israel (Laniado Hospital and Nazareth Hospital) on patients with a diagnosis of fibromyalgia who were treated with MC.” After obtaining patient consent, demographic, clinical, and laboratory parameters were documented. All the patients “also completed the Revised Fibromyalgia Impact Questionnaire regarding the period before and after MC treatment.”

Read moreStudy: Marijuana Effective at Treating Fibromyalgia

New Hampshire Committee Votes to Allow Medical Marijuana for Chronic Pain and PTSD

A legislative committee in New Hampshire has given approval to two bills that would expand the state’s medical marijuana law.

The House Health, Human Services and Elderly Affairs Committee voted 12 to 6 to add chronic pain as a condition that qualifies someone to legally use marijuana for medical purposes. The committee also voted to add post traumatic stress disorder (PTSD) as a qualifying condition, though the vote was considerably closer; 9 to 8.

The current list of qualifying medical cannabis conditions in New Hampshire includes:

Read moreNew Hampshire Committee Votes to Allow Medical Marijuana for Chronic Pain and PTSD

Study: 100% Of Those with Migraines, Fibromyalgia and IBS Find Reduction Of Pain with Marijuana

By The National Pain Report

migrainesOne-hundred percent (100%) of people with migraine headache, fibromyalgia or irritable bowel syndrome who use medical marijuana for a minimum of 30 days report a reduction in pain and discomfort, a 6-month study conducted by Care By Design found.

People included in the survey suffer from a range of different conditions, and some suffer from multiple conditions, including:

Read moreStudy: 100% Of Those with Migraines, Fibromyalgia and IBS Find Reduction Of Pain with Marijuana

Cannabinoid Deficiency May Cause Migraines, Fibromyalgia and Irritable Bowel Syndrome

A meta-study being published in the upcoming issue of the journal NeuroendocrinologyMedicalMarijuana2-JCR.jpg Letters, and published online ahead of print by the U.S. National Institute of Health, has found that cannabinoid deficiency may play a role in migraines, fribromyalgia, irritable bowel syndrome and other medical conditions, indicating that cannabinoid intake may provide a treatment option for these ailments.

For the study; “Available literature was reviewed, including searches via the National Library of medicine database and other sources.”

Read moreCannabinoid Deficiency May Cause Migraines, Fibromyalgia and Irritable Bowel Syndrome